0000924717false00009247172025-02-062025-02-06

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 06, 2025

 

 

Surmodics, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Minnesota

0-23837

41-1356149

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

9924 West 74th Street

 

Eden Prairie, Minnesota

 

55344

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 952 500-7000

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.05 par value

 

SRDX

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Shareholders of Surmodics, Inc. (the “Company”) was held on February 6, 2025. The final voting results on the proposals, which were described in more detail in the Company’s proxy statement filed with the Securities and Exchange Commission on December 19, 2024, are set forth below.

1.
Election of Director. The individual nominated by the Company’s Board of Directors to serve as the Class II director was duly elected by the Company’s shareholders, and the final results of the votes cast are as follows:

 

 

For

 

Withheld

 

Broker Non-Votes

Gary R. Maharaj

 

8,404,069

 

187,820

 

1,908,890

 

2.
Set the Number of Directors. The Company’s shareholders approved the proposal to set the number of directors at five (5) by the following vote:

For

 

Against

 

Abstain

 

 

10,441,062

 

59,413

 

304

 

 

 

3.
Ratification of the Appointment of Deloitte & Touche LLP. The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2025 by the following vote:

For

 

Against

 

Abstain

 

 

10,463,759

 

35,348

 

1,672

 

 

 

4.
Advisory Vote on Executive Compensation. The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the following vote:

For

 

Against

 

Abstain

 

Broker Non-Votes

7,415,339

 

1,043,557

 

132,993

 

1,908,890

 

Item 9.01 Financial Statements and Exhibits.

d) Exhibits.

Exhibit

Number

Description

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

SURMODICS, INC.

 

 

 

 

Date:

February 10, 2025

By:

/s/ Gordon S. Weber

 

 

 

Senior Vice President of Legal, General Counsel and Secretary

 

v3.25.0.1
Document And Entity Information
Feb. 06, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 06, 2025
Entity Registrant Name Surmodics, Inc.
Entity Central Index Key 0000924717
Entity Emerging Growth Company false
Entity File Number 0-23837
Entity Incorporation, State or Country Code MN
Entity Tax Identification Number 41-1356149
Entity Address, Address Line One 9924 West 74th Street
Entity Address, City or Town Eden Prairie
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55344
City Area Code 952
Local Phone Number 500-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.05 par value
Trading Symbol SRDX
Security Exchange Name NASDAQ
Grafico Azioni SurModics (NASDAQ:SRDX)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di SurModics
Grafico Azioni SurModics (NASDAQ:SRDX)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di SurModics